Investor Relations

General

Share Capital
Number of shares
Stock exchanges

Corporate Calendar

June 2022

Publication of annual financial statement as of Dec. 31, 2021

August 2022

Annual General Meeting

September 2022

Publication of half-year report as of June 30, 2022

Highlights

Frankfurter Allgemeine Zeitung
March 29, 2022

Shares with intoxication risk

February 3, 2022

"The over-the-counter trading market of the Düsseldorf Stock Exchange has included Cannovum AG, pharmaceutical wholesaler and manufacturer of high-quality medical cannabis products based in Berlin, in May 2021 - a direct listing of the shares of previous shareholders."

Read more
Sharedeals
March 29, 2022

Cannovum: Unique in the German cannabis market

February 9, 2022

"Cannovum is the first German listed medical cannabis company and therefore has a lot of pioneering work to do. Cannovum wants to set itself apart from the competition with sustainable and organic production. Sun-ripened cannabis without pesticides: this unique selling point is what Marten wants to make the industry standard in a few years."

Read more
Deutsche Wirtschaftsnachrichten
March 29, 2022

Our prices are not higher than those on the black market

January 1, 2022

"It is important for us to apply the knowledge we have gained in the medical segment to the consumer segment. This includes the quality of the product on offer. We would like to see pharmaceutical grade quality in the over-the-counter cannabis market as well."

Read more

Reports

DGAP

Ad Hoc

No Ad Hoc reports yet.

Sign-Up for the
Investors Newsletter

Get the latest information and insights about the medical cannabis industry in Germany.

Successfully signed-up
There was an error.

Contact us

Contact form

Erfolgreich abgesendet
Something went wrong while submitting the form.

Contact information

For investors:
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.